Australia markets closed

Evaxion Biotech A/S (EVAX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.1020+0.1020 (+3.40%)
As of 12:57PM EDT. Market open.
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
Operating expenses
Research development
13,691
17,056
19,583
10,902
Selling general and administrative
10,525
8,066
6,180
5,654
Total operating expenses
24,358
25,264
25,834
16,568
Operating income or loss
-24,358
-25,264
-25,834
-16,568
Interest expense
666
798
159
29
Total other income/expenses net
-
2,108
1,283
22
Income before tax
-25,260
-23,941
-24,710
-16,575
Income tax expense
-786
-772
-178
-1,557
Income from continuing operations
-24,474
-23,169
-24,532
-15,018
Net income
-24,474
-23,169
-24,532
-15,018
Net income available to common shareholders
-24,474
-23,169
-24,532
-15,018
Basic EPS
-9.50
-9.80
-12.60
-9.27
Diluted EPS
-9.50
-9.80
-12.60
-9.27
Basic average shares
2,609
2,364
1,949
1,620
Diluted average shares
2,609
2,364
1,949
1,620